Danaher Corp. logo

DHR

Danaher Corp.

$200.14
-0.19%
Last updated 6:04 AM
Danaher Corp logo

Danaher Corp

Danaher Corp is a Life Sciences Tools & Services company listed on NEW YORK STOCK EXCHANGE, INC..

Industry
Life Sciences Tools & Services
Exchange
NEW YORK STOCK EXCHANGE, INC.
Market Cap
$140.7B
P/E Ratio
35.1
Cash on Hand
$4.6B(positive)
Shares Outstanding
703.0M shares
Currency
USD
Visit website →

About

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.

via Wikipedia →

Earnings (EPS)

QuarterEPS EstimateEPS Actual
Q2 2026$1.85$1.94
Q1 2026$1.96$2.06
Q4 2025$2.17$2.23
Q3 2025$1.74$1.89

Financial Highlights

The basics, explained simply — no finance degree required.

52-Week Range
$160.93 – $242.80

The lowest and highest price this stock has traded at over the past year.

Dividend Yield
0.49%

How much this stock pays you back each year, just for holding it — as a % of the share price.

Profit Margin
15.9%

How much of every $1 in sales turns into actual profit. Higher generally means a healthier business.

Revenue Growth
+4.6%

How much the company's sales grew compared to a year ago.

Volatility (Beta)
0.80

How much this stock tends to swing compared to the overall market. Above 1 means it typically moves more than the market (higher risk, higher potential reward); below 1 means it's historically calmer.

Analyst Insights

Analyst Consensus
Buy

Based on 32 analysts

Next Earnings
Oct 19, 2026
Similar Companies

Insider Activity

Recent buys and sells by company executives and directors — publicly disclosed, as required by law.

Blair Rainer
Aug 21, 2026 • $217.77/share
Sold 11,307
Blair Rainer
Aug 21, 2026 • $218.73/share
Sold 39,193
Blair Rainer
Aug 21, 2026 • $219.35/share
Sold 7,755
RALES STEVEN M
Aug 4, 2026
Bought 500,000
RALES STEVEN M
Aug 4, 2026
Bought 1,000,000
RALES MITCHELL P
Aug 4, 2026
Bought 500,000

Recent News